We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
CABENUVA cabotegravir 400 mg/2 mL plus rilpivirine 600 mg/2 mL prolonged-release suspensions for injection vials (323784)
ARTG ID 323784
ARTG Name
CABENUVA cabotegravir 400 mg/2 mL plus rilpivirine 600 mg/2 mL prolonged-release suspensions for injection vials
Product name
CABENUVA cabotegravir 400 mg/2 mL plus rilpivirine 600 mg/2 mL prolonged-release suspensions for injection vials
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
cabotegravir
rilpivirine
Licence category
RE
Licence status
A
Summary
Product information
Consumer medicine information